Alterations of VLDL composition during alimentary lipemia

Journal of Lipid Research

Volumn 38, Issue 2, 1997, Pages 301-314

  Björkegren, Johan ^a   Hamsten, Anders ^a   Milne, Ross W ^b   Karpe, Fredrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

apoB 100; apoC I; apoC II; apoc III; apoE; triglyceride rich lipoproteins

Indexed keywords

APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; CHYLOMICRON; LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; FAT INTAKE; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOAFFINITY CHROMATOGRAPHY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030980480     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Gotto, A. M., Jr., H. J. Pownall, and R. J. Havel. 1986. Introduction to the plasma lipoproteins. Methods Enzymol. 128: 3-41.
2. Kane, J. P., D. A. Hardman, and H. E. Paulus. 1980. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc. Natl. Acad. Sci. USA. 77: 2465-2469.
3. Havel, R. J., J. P. Kane, and M. L. Kashyap. 1973. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J. Clin. Invest. 52: 32-38.
4. Tornoci, L., C. A. Scheraldi, X. Li, H. Ide, I. J. Goldberg, and N. A. Le. 1993. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II, further evidence for the presence of non-equilibrating pools of apoC-II and apoC-III in plasma lipoproteins. J. Lipid Res. 34: 1793-1803.
5. Havel, R. J. 1995. Chylomicron remnants: hepatic receptors and metabolism. Curr. Opin. Lipidol. 6: 312-316.
6. f 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J. Biol. Chem. 258: 4526-4533.
7. Eisenberg, S., G. Friedman, and T. Vogel. 1988. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3. Arterioscler. Thromb. 8: 480-487.
8. Shelburne, F., J. Hanks, W. Meyers, and S. Quarfordt. 1980. Effects of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J. Clin. Invest. 65: 652-658.
9. LaRosa, J. C., R. I. Levy, P. Herbert, S. E. Lux, and D. S. Fredrickson. 1970. A specific apoprotein activator for lipoprotein lipase. Biochem. Biophys. Res. Commun. 41: 57-62.
10. Brown, W. V., and M. L. Baginsky. 1972. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem. Biophys. Res. Commun. 46: 375-382.
11. Wang, C-S., W. J. McConathy, H. U. Kloer, and P. Alaupovic. 1985. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest. 75: 384-390.
12. Windler, E., Y. Chao, and R. J. Havel. 1980. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins. J. Biol. Chem. 255: 8303-8307.
13. Windler, E., and R. J. Havel. 1985. Inhibitory effect of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J. Lipid Res. 26: 556-565.
14. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
15. deSilva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.
16. Shachter, N. S., T. Hayek, T. Leff, J. D. Smith, D. W. Rosenberg, A. Walsh, R. Ramakrishnan, I. J. Goldberg, H. N. Ginsberg, and J. L. Breslow. 1994. Overexpression of apolipoprotein C-II causes hypertriglyceridemia in transgenic mice. J. Clin. Invest. 93: 1683-1690.
17. Weisgraber, K. H., R. W. Mahley, R. C. Kowal, J. Herz, J. L. Goldstein, and M. S. Brown. 1990. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 22453-22459.
18. Sehayek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266: 18259-18267.
19. Shachter, N. S., T. Ebara, R. Ramakrishnan, G. Steiner, J. L. Breslow, H. N. Ginsberg, and J. D. Smith. 1996. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein CI. J. Clin. Invest. 98: 468-855.
20. Cohn, J. S., J. R. M. Namara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J. Lipid Res. 29: 925-936.
21. Cohn, J. S., E. J. Johnson, J. S. Millar, S. D. Cohn, R. W. Milne, Y. L. Marcel, R. M. Russell, and E. J. Schaefer. 1993. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J. Lipid Res. 34: 2033-2040.
22. Karpe, F., G. Steiner, T. Olivercrona, L. A. Carlson, and A. Hamsten. 1993. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 91: 748-759.
23. Schneeman, B. O., L. Kotite, K. M. Todd, and R. J. Havel. 1993. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc. Natl Acad. Sci. USA. 90: 2069-2073.
24. Gianturco, S. H., F. B. Brown, A. M. J. Gotto, and W. A. Bradley. 1982. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J. Lipid Res. 23: 984-993.
25. Björkegren, J., C. J. Packard, A. Hamsten, D. Bedford, M. Caslake, J. Shepherd, L. Foster, P. Stewart, and F. Karpe. 1996. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicronlike triglyceride emulsion reflects competition for a common lipolytic pathway. J. Lipid Res. 37: 76-86.
26. Karpe, F., and M. Hultin. 1995. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J. Lipid Res. 36: 1557-1566.
27. Milne, R. W., R. Theolis, R. B. J. Verdery, and Y. L. Marcel. 1983. Characterization of monoclonal antibodies against LDL. Arteriosclerosis. 3: 23-30.
28. Hixson, J. E., A. McMahan, H. C. J. McGill, and J. P. Strong. 1992. Apolipoprotein B insertion/deletion polymorphism is associated with atherosclerosis in young black but not young white males. Arterioscler. Thromb. 12: 1023-1029.
29. Carlson, K. 1973. Lipoprotein fractionation. J. Clin. Pathol. 26: 32-37.
30. Food Compositional Tables. 1993. Liber Tryck AB, Uppsala, Sweden.
31. Marcel, Y. L., M. Hogue, R. Theolis, and R. W. Milne. 1982. Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against LDL. J. Biol. Chem. 257: 13165-13168.
32. Milne, R. W., P. K. Weech, L. Blanchette, J. Davignon, P. I. Alaupovic, and Y. L. Marcel. 1984. Isolation and characterization of apolipoprotein B-48 and apoB-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J. Clin. Invest. 73: 816-823.
33. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
34. Zlatkis, A., B. Zak, and A. Boyle. 1953. A new method for direct determination of serum cholesterol. J. Lab. Clin. Med. 41: 486-492.
35. Karpe, F., and A. Hamsten. 1994. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J. Lipid Res. 35: 1311-1317.
36. Kane, J. P. 1973. A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins. Anal. Biochem. 53: 350-364.
37. Snedecor, G. W., and W. G. Cochran. 1971. Statistical Methods. Iowa University Press, Ames, LA.
38. Terce, F. R., R. W. Milne, P. K. Weech, J. Davignon, and Y. L. Marcel. 1985. Apolipoprotein B-48 and B-100 very low density lipoproteins. Comparison in dysbetalipoproteinemia (type III) and familial hypertriglyceridemia (type IV). Arteriosclerosis. 5: 201-211.
39. Ji, Z. S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and the uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
40. Ji, Z. S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36: 583-592.
41. Bradley, W. A., and S. H. Gianturco. 1986. ApoE is necessary and sufficient for the binding of large very low density lipoproteins to the LDL receptor; apo B is unnecessary. J. Lipid Res. 27: 40-48.
42. Yamada, N., D. M. Shames, J. B. Stoudemire, and R. J. Havel. 1986. Metabolism of lipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipoprotein E. Proc. Natl. Acad. Sci. USA. 83: 3479-3483.
43. Yamada, N., D. M. Shames, K. Takahashi, and R. J. Havel. 1988. Metabolism of apolipoprotein B-100 in large very low density lipoproteins of blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits. J. Clin. Invest. 82: 2106-2113.
44. Agnani, G., J. M. Bard, L. Candelier, S. Delattre, J. C. Fruchart, and V. Clavey. 1991. Interaction of LpB, LpB:E, LpB:C-III and LpB:-C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler. Thromb. 11: 1021-1029.
45. Sehayek, E., and S. Eisenberg. 1990. Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal metabolism. Arteriosclerosis. 10: 1088-1096.
46. Shimano, H., N. Yamada, M. Katsuki, K. Yamamoto, T. Gotoda, K. Harada, M. Shimada, and Y. Yazaki. 1992. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B. J. Clin. Invest. 90: 2084-2091.
47. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
48. Brown, M. S., J. Herz, R. C. Kowal, and J. L. Goldstein. 1991. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr. Opin. Lipidol. 2: 65-72.
49. Connelly, P. W., G. F. Maguire, C. Vezina, R. A. Hegele, and A. Kuksis. 1994. Kinetics of lipolysis of very low density lipoprotein by lipoprotein lipase. J. Biol. Chem. 269: 20554-20560.
50. Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII and E. Arterioscler. Thromb. Vasc. Biol. 15: 963-971.
51. Yang, C., Z-W. Gu, N. Valentinova, H. J. Pownall, B. Lee, M. Yang, Y-h. Xie, J. R. Guyton, T. N. Vlasik, J. C. Fruchart, and A. M. Gotto. 1993. Human very low density lipoprotein structure: interaction of the C apolipoproteins with apolipoprotein B-100. J. Lipid Res. 34: 1311-1321.
52. Campos, E., S. Jäckle, G. C. Chen, and R. J. Havel. 1996. Isolation and characterization of two distinct species of human very low density lipoproteins lacking apolipoprotein E. J. Lipid Res. 37: 1897-1906.
53. Scow, R. O., and T. Olivercrona. 1978. Effect of albumin on products formed from chylomicron triaglycerol by lipoprotein lipase in vitro. Biochim. Biophys. Acta. 487: 472-486.
54. Ginsberg, H. N., N-A. Le, I. J. Goldberg, J. C. Gibson, A. Rubinstein, P. Wang-Iverson, R. Norum, and W. V. Brown. 1986. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. J. Clin. Invest. 78: 1287-1295.
55. Maeda, N., H. Li, D. Lee, P. Oliver, S. Quarfordt, and J. Osada. 1994. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269: 23610-23616.
56. Tornvall, P., P. Båvenholm, C. Landou, U. d. Faire, and A. Hamsten. 1993. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction. Circulation. 88: 2180-2189.
57. Phillips, N. R., D. Waters, and R. J. Havel. 1993. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88: 2762-2770.
58. Campos, E., K. Nakajima, A. Tanaka, and R. J. Havel. 1992. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J. Lipid Res. 33: 369-380.
59. Van Lenten, B. J., A. M. Fogelman, R. L. Jackson, S. Shapiro, M. E. Haberland, and P. A. Edwards. 1985. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocytes-macrophages. J. Biol. Chem. 260: 8783-8788.
60. Huff, M. V., A. J. Evans, C. G. Sawyez, B. M. Wolfe, and P. J. Nestel. 1991. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Arterioscler. Thromb. 11: 221-233.
61. Rapp, J. H., A. Lespine, R. L. Hamilton, N. Colyvas, A. H. Chaumeton, J. Tweedie-Hardman, L. Kotite, S. T. Kunitake, R. J. Havel, and J. P. Kane. 1994. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 14: 1767-1774.